Cumplimiento terapéutico con terapias modificadoras de la enfermedad de primera línea en pacientes con esclerosis múltiple. Estudio COMPLIANCE
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical)
Reference43 articles.
1. Epidemiology of multiple sclerosis in Europe: A review;Koutsouraki;Int Rev Psychiatry,2010
2. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability;Weinshenker;Brain,1989
3. Multiple sclerosis: Current treatment algorithms;Río;Curr Opin Neurol,2011
4. Adherence to long-term therapies: Evidence for action;Sabate,2003
5. Impact of adherence to interferons in the treatment of multiple sclerosis: A non-experimental, retrospective, cohort study;Steinberg;Clin Drug Investig,2010
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world persistence and adherence of ofatumumab versus oral and injectable disease-modifying therapies in patients with multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-09
2. Barriers and strategies to medication adherence amongst people with multiple sclerosis and cognitive problems;Multiple Sclerosis and Related Disorders;2024-08
3. Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer;JAMA Network Open;2024-05-17
4. Adherencia al tratamiento en pacientes con esclerosis múltiple: factores de riesgo;Neurología;2024-05
5. Patient compliance: A concept analysis;Belitung Nursing Journal;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3